Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents.

Giuseppe Montalto, Manfredi Rizzo, Dragana Nikolic, Nicola Abate, Ali A. Rizvi, Manfredi Rizzo, Hanaa S. Sallam

Risultato della ricerca: Article

7 Citazioni (Scopus)

Abstract

Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity. These inflammatory markers are collectively referred to as adipocytokines, or adipokines. Adipose tissue's functional capacity and metabolic activity vary among individuals, thus partly explaining the incomplete overlap between obesity and the metabolic syndrome. The functional failure of adipose tissues results in changed energy delivery and impaired glucose consumption, triggering self-regulatory mechanisms to maintain homeostasis. Antihyperglycemic, hypolipidemic, antiobesity, and angiotensin II receptor blocker drugs influence adipokine levels in different ways. However, clinical data are still scarce and the clinical relevance of these effects needs to be fully determined.
Lingua originaleEnglish
pagine (da-a)1-10
Numero di pagine9
RivistaMetabolic Syndrome and Related Disorders
Volume12
Stato di pubblicazionePublished - 2014

Fingerprint

Hypolipidemic Agents
Adipokines
Hypoglycemic Agents
Lipoproteins
Adipose Tissue
Angiotensin Receptor Antagonists
Energy Metabolism
Insulin Resistance
Homeostasis
Obesity
Hormones
Glucose
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cita questo

Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. / Montalto, Giuseppe; Rizzo, Manfredi; Nikolic, Dragana; Abate, Nicola; Rizvi, Ali A.; Rizzo, Manfredi; Sallam, Hanaa S.

In: Metabolic Syndrome and Related Disorders, Vol. 12, 2014, pag. 1-10.

Risultato della ricerca: Article

@article{ffc4efaa3751498b9e2dad954cfcc8fa,
title = "Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents.",
abstract = "Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity. These inflammatory markers are collectively referred to as adipocytokines, or adipokines. Adipose tissue's functional capacity and metabolic activity vary among individuals, thus partly explaining the incomplete overlap between obesity and the metabolic syndrome. The functional failure of adipose tissues results in changed energy delivery and impaired glucose consumption, triggering self-regulatory mechanisms to maintain homeostasis. Antihyperglycemic, hypolipidemic, antiobesity, and angiotensin II receptor blocker drugs influence adipokine levels in different ways. However, clinical data are still scarce and the clinical relevance of these effects needs to be fully determined.",
author = "Giuseppe Montalto and Manfredi Rizzo and Dragana Nikolic and Nicola Abate and Rizvi, {Ali A.} and Manfredi Rizzo and Sallam, {Hanaa S.}",
year = "2014",
language = "English",
volume = "12",
pages = "1--10",
journal = "Metabolic Syndrome and Related Disorders",
issn = "1540-4196",
publisher = "Mary Ann Liebert Inc.",

}

TY - JOUR

T1 - Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents.

AU - Montalto, Giuseppe

AU - Rizzo, Manfredi

AU - Nikolic, Dragana

AU - Abate, Nicola

AU - Rizvi, Ali A.

AU - Rizzo, Manfredi

AU - Sallam, Hanaa S.

PY - 2014

Y1 - 2014

N2 - Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity. These inflammatory markers are collectively referred to as adipocytokines, or adipokines. Adipose tissue's functional capacity and metabolic activity vary among individuals, thus partly explaining the incomplete overlap between obesity and the metabolic syndrome. The functional failure of adipose tissues results in changed energy delivery and impaired glucose consumption, triggering self-regulatory mechanisms to maintain homeostasis. Antihyperglycemic, hypolipidemic, antiobesity, and angiotensin II receptor blocker drugs influence adipokine levels in different ways. However, clinical data are still scarce and the clinical relevance of these effects needs to be fully determined.

AB - Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity. These inflammatory markers are collectively referred to as adipocytokines, or adipokines. Adipose tissue's functional capacity and metabolic activity vary among individuals, thus partly explaining the incomplete overlap between obesity and the metabolic syndrome. The functional failure of adipose tissues results in changed energy delivery and impaired glucose consumption, triggering self-regulatory mechanisms to maintain homeostasis. Antihyperglycemic, hypolipidemic, antiobesity, and angiotensin II receptor blocker drugs influence adipokine levels in different ways. However, clinical data are still scarce and the clinical relevance of these effects needs to be fully determined.

UR - http://hdl.handle.net/10447/104542

UR - http://www.ncbi.nlm.nih.gov/pubmed/24206170

M3 - Article

VL - 12

SP - 1

EP - 10

JO - Metabolic Syndrome and Related Disorders

JF - Metabolic Syndrome and Related Disorders

SN - 1540-4196

ER -